BE Of India, GSK Biologicals Said In Early Stages Of Merger Talk
This article was originally published in PharmAsia News
Executive Summary
India's Biological E vaccine division is discussing a purchase proposal offered by Belgium-based GlaxoSmithKline Biologicals, according to sources